References

Safe de-labeling of patients at low risk of penicillin allergy in Denmark

10.1159/000521708 · 2022 · External reference

Implementation of a pharmacist-led penicillin allergy de-labelling service in a public hospital

10.1093/jac/dky575 · 2019 · External reference

Penicillin allergy delabeling has a significant impact on subsequent antibiotic use in primary care

10.1016/j.waojou.2024.100958 · 2024 · External reference

De-labelling penicillin allergy in acutely hospitalized patients: a pilot study

10.1186/s12879-021-06794-1 · 2021 · External reference

Delabeling of penicillin allergy: room for improvement

10.1159/000530770 · 2023 · External reference

Self-reported drug allergy in a general adult Portuguese population

10.1111/j.1365-2222.2004.02070.x · 2004 · External reference

Frequency of self-reported drug allergy: a systematic review and meta-analysis with meta-regression

10.1016/j.anai.2017.07.009 · 2017 · External reference

The impact of penicillin allergy labels on antibiotic and health care use in primary care: a retrospective cohort study

10.1186/s13601-017-0154-y · 2017 · External reference

Health care use and serious infection prevalence associated with penicillin “allergy” in hospitalized patients: a cohort study

10.1016/j.jaci.2013.09.021 · 2014 · External reference

The impact of a reported penicillin allergy on surgical site infection risk

10.1093/cid/cix794 · 2018 · External reference

Association between penicillin allergy labels and serious adverse events in hospitalized patients: a systematic review and meta-analysis

10.3389/fphar.2024.1519522 · 2025 · External reference

Changing patterns in the epidemiology of drug allergy

10.1111/all.15970 · 2024 · External reference

Antibiotic use in Australian and Swedish primary care: a cross-country comparison

10.1080/02813432.2022.2036494 · 2022 · External reference

Exploring the One Health perspective in Sweden’s policies for containing antibiotic resistance

10.3390/antibiotics10050526 · 2021 · External reference

Lessons learnt during 20 years of the Swedish strategic programme against antibiotic resistance

10.2471/blt.16.184374 · 2017 · External reference

Negative impact of penicillin allergy labels on antibiotic use in hospitalized patients in Chinese mainland

10.1016/j.waojou.2022.100677 · 2022 · External reference

De-labelling penicillin allergy in acutely hospitalized patients: a pilot study

10.1186/s12879-021-06794-1 · 2021 · External reference

Assessing the prevalence and characteristics of self-reported penicillin allergy in Saudi Arabian population: a nationwide cross-sectional study

10.1016/j.jsps.2022.12.006 · 2023 · External reference

Higher risk of revision for infection using systemic clindamycin prophylaxis than with cloxacillin

10.1080/17453674.2017.1324677 · 2017 · External reference

Trends in antibiotic use in Danish, Finnish, Norwegian and Swedish children

10.2147/clep.s362262 · 2022 · External reference

Measuring hospital antibiotic consumption in EU/EEA countries: comparison of different metrics, 2017 to 2021

10.2807/1560-7917.es.2024.29.46.2400317 · 2024 · External reference

EAACI/ENDA position paper on drug provocation testing

10.1111/all.15996 · 2024 · External reference

Drug allergy: a 2022 practice parameter update

10.1016/j.jaci.2022.08.028 · 2022 · External reference

Prevalence and characteristics of reported penicillin allergy in an urban outpatient adult population

10.2500/aap.2014.35.3791 · 2014 · External reference

European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe

10.1093/jac/dkl186 · 2006 · External reference

Effectiveness of interventions that support penicillin allergy assessment and de-labeling of patients by non-allergy specialists: a systematic review protocol

10.11124/jbies-21-00075 · 2022 · External reference

Implementation of a pharmacist-led outpatient penicillin allergy testing clinic

10.1016/j.japh.2025.102346 · 2025 · External reference